Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in U.S. Streams, 1999-2000: A National Reconnaissance
U.S. Geological Survey, 400 S. Clinton Street, Box 1230, Iowa City, Iowa 52244
U.S. Geological Survey, Box 25046, MS 407, Denver, Colorado 80225-0046
U.S. Geological Survey, 4500 SW 40th Avenue, Ocala, Florida 34474
U.S. Geological Survey, 4821 Quail Crest Place, Lawrence, Kansas 66049
U.S. Geological Survey, Box 25046, MS 407, Denver, Colorado 80225-0046
U.S. Geological Survey, 3215 Marine Street, Boulder, Colorado 80303
U.S. Geological Survey, 810 Bear Tavern Road, West Trenton, New Jersey 08628
Received for review June 12, 2001
Revised manuscript received November 26, 2001
Accepted December 12, 2001
Abstract:
To provide the first nationwide reconnaissance of the occurrence of pharmaceuticals, hormones, and other organic wastewater contaminants (OWCs) in water resources, the U.S. Geological Survey used five newly developed analytical methods to measure concentrations of 95 OWCs in water samples from a network of 139 streams across 30 states during 1999 and 2000. The selection of sampling sites was biased toward streams susceptible to contamination (i.e. downstream of intense urbanization and livestock production). OWCs were prevalent during this study, being found in 80% of the streams sampled. The compounds detected represent a wide range of residential, industrial, and agricultural origins and uses with 82 of the 95 OWCs being found during this study. The most frequently detected compounds were coprostanol (fecal steroid), cholesterol (plant and animal steroid), N,N-diethyltoluamide (insect repellant), caffeine (stimulant), triclosan (antimicrobial disinfectant), tri(2-chloroethyl)phosphate (fire retardant), and 4-nonylphenol (nonionic detergent metabolite). Measured concentrations for this study were generally low and rarely exceeded drinking-water guidelines, drinking-water health advisories, or aquatic-life criteria. Many compounds, however, do not have such guidelines established. The detection of multiple OWCs was common for this study, with a median of seven and as many as 38 OWCs being found in a given water sample. Little is known about the potential interactive effects (such as synergistic or antagonistic toxicity) that may occur from complex mixtures of OWCs in the environment. In addition, results of this study demonstrate the importance of obtaining data on metabolites to fully understand not only the fate and transport of OWCs in the hydrologic system but also their ultimate overall effect on human health and the environment.
The continued exponential growth in human population has created a corresponding increase in the demand for the Earth's limited supply of freshwater. Thus, protecting the integrity of our water resources is one of the most essential environmental issues of the 21st century. Recent decades have brought increasing concerns for potential adverse human and ecological health effects resulting from the production, use, and disposal of numerous chemicals that offer improvements in industry, agriculture, medical treat ment, and even common household conveniences (1). Research has shown that many such compounds can enter the environment, disperse, and persist to a greater extent than first anticipated. Some compounds, such as pesticides, are intentionally released in measured applications. Others, such as industrial byproducts, are released through regulated and unregulated industrial discharges to water and air resources. Household chemicals, pharmaceuticals, and other consumables as well as biogenic hormones are released directly to the environment after passing through wastewater treatment processes (via wastewater treatment plants, or domestic septic systems), which often are not designed to remove them from the effluent (2). Veterinary pharmaceuticals used in animal feeding operations may be released to the environment with animal wastes through overflow or leakage from storage structures or land application (3). As a result, there are a wide variety of transport pathways for many different chemicals to enter and persist in environmental waters.
Surprisingly, little is known about the extent of environmental occurrence,
transport, and ultimate fate of many synthetic organic chemicals after their
intended use, particularly hormonally active chemicals (4),
personal care products, and pharmaceuticals that are designed to stimulate a
physiological response in humans, plants, and animals (1,
5)
The primary objective of this study is to provide the first nationwide reconnaissance of the occurrence of a broad suite of 95 organic wastewater contaminants (OWCs), including many compounds of emerging environmental concern, in streams across the United States. These OWCs are potentially associated with human, industrial, and agricultural wastewaters and include antibiotics, other prescription drugs, nonprescription drugs, steroids, reproductive hormones, personal care products, products of oil use and combustion, and other extensively used chemicals. The target OWCs were selected because they are expected to enter the environment through common wastewater pathways, are used in significant quantities, may have human or environmental health implications, are representative or potential indicators of certain classes of compounds or sources, and/or can be accurately measured in environmental samples using avail able technologies. Although these 95 OWCs are just a small subset of compounds being used by society, they represent a starting point for this investigation examining the transport of OWCs to water resources of the United States.
This paper describes the analytical results available from 139 streams sampled during 1999-2000 (Figure 1). The results are intended to determine if OWCs are entering U.S. streams and to estimate the extent of their co-occurrence in susceptible waters. In addition, this study provides a focal point for the development and testing of new laboratory methods for measuring OWCs in environmental samples at trace levels, an interpretive context for future assessments of OWCs, and a means for establishing research priorities and future monitoring strategies. More complete interpretations, including an evaluation of the role of potential sources of contamination, will follow in subsequent papers.
![]() |
Figure 1 Location of 139 stream sampling sites. |
Little data were available on the occurrence of most of the targeted OWCs in U.S. streams at the onset of this investiga tion. Therefore, the selection of sampling sites primarily focused on areas considered susceptible to contamination from human, industrial, and agricultural wastewater. The 139 stream sites sampled during 1999-2000 (Figure 1) represent a wide range of geography, hydrogeology, land use, climate, and basin size. Specific information on the individual sampling sites is provided elsewhere (20).
All samples were collected by U.S. Geological Survey personnel using
consistent protocols and procedures designed to obtain a sample representative
of the streamwaters using standard depth and width integrating techniques (21).
At each site, a composite water sample was collected from about 4-6 vertical
profiles which was split into appropriate containers for shipment to the
participating laboratories. For those bottles requiring filtration, water was
passed through a 0.7
m, baked, glass-fiber filter in the
field where possible, or else filtration was conducted in the laboratory. Water
samples for each chemical analysis were stored in precleaned-amber, glass
bottles and collected in duplicate. The duplicate samples were used for backup
purposes (in case of breakage of the primary sample) and for laboratory
replicates. Following collection, samples were immediately chilled and sent to
the laboratory. To minimize contamination of samples, use of personal care items
(i.e. insect repellents, colognes, perfumes), caffeinated products, and tobacco
were discouraged during sample collection and processing.
Each stream site was sampled once during the 1999-2000 study period. Samples collected in 1999 were analyzed for a subset of the OWCs based on the watershed land-use characteristics. Samples collected in 2000 were analyzed for the complete suite of OWCs. The analytical results for each stream sample are available elsewhere (20).
|
chemical (method) |
CASRN |
N |
RL ( |
freq (%) |
max ( |
med ( |
use |
MCL or HAL (23) ( |
lowest LC50 for the most sensitive indicator species ( |
|
Veterinary and Human Antibiotics |
|||||||||
|
carbodox (1) |
6804-07-5 |
104 |
0.10 |
0 |
ND |
ND |
antibiotic |
- |
-/1 |
|
chlortetracycline (1) |
57-62-5 |
115 |
0.05 |
0 |
ND |
ND |
antibiotic |
- |
88000a/3 |
|
chlortetracycline (2) |
57-62-5 |
84 |
0.10 |
2.4 |
0.69 |
0.42 |
antibiotic |
- |
88000a/3 |
|
ciprofloxacin (1) |
85721-33-1 |
115 |
0.02 |
2.6 |
0.03 |
0.02 |
antibiotic |
- |
-/0 |
|
doxycycline (1) |
564-25-0 |
115 |
0.1 |
0 |
ND |
ND |
antibiotic |
- |
-/0 |
|
enrofloxacin (1) |
93106-60-6 |
115 |
0.02 |
0 |
ND |
ND |
antibiotic |
- |
40b/29 |
|
erythromycin-H2O (1) |
114-07-8 |
104 |
0.05 |
21.5 |
1.7 |
0.1 |
erythromycin metabolite |
- |
665000b/35 |
|
lincomycin (1) |
154-21-2 |
104 |
0.05 |
19.2 |
0.73 |
0.06 |
antibiotic |
- |
-/0 |
|
norfloxacin (1) |
70458-96-7 |
115 |
0.02 |
0.9 |
0.12 |
0.12 |
antibiotic |
- |
-/6 |
|
oxytetracycline (1) |
79-57-2 |
115 |
0.1 |
0 |
ND |
ND |
antibiotic |
- |
102000a/46 |
|
oxytetracycline (2) |
79-57-2 |
84 |
0.10 |
1.2 |
0.34 |
0.34 |
antibiotic |
- |
102000a/46 |
|
roxithromycin (1) |
80214-83-1 |
104 |
0.03 |
4.8 |
0.18 |
0.05 |
antibiotic |
- |
-/0 |
|
sarafloxacin (1) |
98105-99-8 |
115 |
0.02 |
0 |
ND |
ND |
antibiotic |
- |
-/0 |
|
sulfachloropyridazine (2) |
80-32-0 |
84 |
0.05 |
0 |
ND |
ND |
antibiotic |
- |
-/0 |
|
sulfadimethoxine (1) |
122-11-2 |
104 |
0.05 |
0 |
ND |
ND |
antibiotic |
- |
-/5 |
|
sulfadimethoxine (2) |
122-11-2 |
84 |
0.05 |
1.2 |
0.06 |
0.06 |
antibiotic |
- |
-/5 |
|
sulfamerazine (1) |
127-79-7 |
104 |
0.05 |
0 |
ND |
ND |
antibiotic |
- |
100000c/17 |
|
sulfamerazine (2) |
127-79-7 |
84 |
0.05 |
0 |
ND |
ND |
antibiotic |
- |
100000c/17 |
|
sulfamethazine (1) |
57-68-1 |
104 |
0.05 |
4.8 |
0.12 |
0.02 |
antibiotic |
- |
100000c 17 |
|
sulfamethazine (2) |
57-68-1 |
84 |
0.05 |
1.2 |
0.22 |
0.22 |
antibiotic |
- |
100000c/17 |
|
sulfamethizole (1) |
144-82-1 |
104 |
0.05 |
1.0 |
0.13 |
0.13 |
antibiotic |
- |
-/0 |
|
sulfamethoxazole (1) |
723-46-6 |
104 |
0.05 |
12.5 |
1.9 |
0.15 |
antibiotic |
- |
-/0 |
|
sulfamethoxazole (3) |
723-46-6 |
84 |
0.023 |
19.0 |
0.52 |
0.066 |
antibiotic |
- |
-/0 |
|
sulfathiazole (1) |
72-14-0 |
104 |
0.10 |
0 |
ND |
ND |
antibiotic |
- |
-/0 |
|
sulfathiazole (2) |
72-14-0 |
84 |
0.05 |
0 |
ND |
ND |
antibiotic |
- |
-/0 |
|
tetracycline (1) |
60-54-8 |
115 |
0.05 |
0 |
ND |
ND |
antibiotic |
- |
550000b/3 |
|
tetracycline (2) |
60-54-8 |
84 |
0.10 |
1.2 |
0.11 |
0.11 |
antibiotic |
- |
550000b/3 |
|
trimethoprim (1) |
738-70-5 |
104 |
0.03 |
12.5 |
0.71 |
0.15 |
antibiotic |
- |
3000c/4 |
|
trimethoprim (3) |
738-70-5 |
84 |
0.014 |
27.4 |
0.30 |
0.013 |
antibiotic |
- |
3000c/4 |
|
tylosin (1) |
1401-69-0 |
104 |
0.05 |
13.5 |
0.28 |
0.04 |
antibiotic |
- |
-/0 |
|
virginiamycin (1) |
21411-53-0 |
104 |
0.10 |
0 |
ND |
ND |
antibiotic |
- |
-/0 |
|
Prescription Drugs |
|||||||||
|
albuterol (salbutamol) (3) |
18559-94-9 |
84 |
0.029 |
0 |
ND |
ND |
antiasthmatic |
- |
-/0 |
|
cimetidine (3) |
51481-61-9 |
84 |
0.007 |
9.5 |
0.58d |
0.074d |
antacid |
- |
-/0 |
|
codeine (3) |
76-57-3 |
46 |
0.24 |
6.5 |
0.019 |
0.012 |
analgesic |
- |
-/0 |
|
codeine (4) |
76-57-3 |
85 |
0.1 |
10.6 |
1.0d |
0.2d |
analgesic |
- |
-/0 |
|
dehydronifedipine (3) |
67035-22-7 |
84 |
0.01 |
14.3 |
0.03 |
0.012 |
antianginal |
- |
-/0 |
|
digoxin (3) |
20830-75-5 |
46 |
0.26 |
0 |
NDd |
NDd |
cardiac stimulant |
- |
10000000a/24 |
|
digoxigenin (3) |
1672-46-4 |
84 |
0.008 |
0 |
ND |
ND |
digoxin metabolite |
- |
-/0 |
|
diltiazem (3) |
42399-41-7 |
84 |
0.012 |
13.1 |
0.049 |
0.021 |
antihypertensive |
- |
-/0 |
|
enalaprilat (3) |
76420-72-9 |
84 |
0.15 |
1.2 |
0.046d |
0.046d |
enalapril maleate (antihypertensive) metabolite |
- |
-/0 |
|
fluoxetine (3) |
54910-89-3 |
84 |
0.018 |
1.2 |
0.012d |
0.012d |
antidepressant |
- |
-/0 |
|
gemfibrozil (3) |
25812-30-0 |
84 |
0.015 |
3.6 |
0.79 |
0.048 |
antihyperlipidemic |
- |
-/0 |
|
metformin (3) |
657-24-9 |
84 |
0.003 |
4.8 |
0.15d |
0.11d |
antidiabetic |
- |
-/0 |
|
paroxetine metabolite (3) |
- |
84 |
0.26 |
0 |
NDd |
NDd |
paroxetine (antidepressant) metabolite |
- |
-/0 |
|
ranitidine (3) |
66357-35-5 |
84 |
0.01 |
1.2 |
0.01d |
0.01d |
antacid |
- |
-/0 |
|
warfarin (3) |
81-81-2 |
84 |
0.001 |
0 |
ND |
ND |
anticoagulant |
- |
16000c/ 33 |
|
Nonprescription Drugs |
|||||||||
|
acetaminophen (3) |
103-90-2 |
84 |
0.009 |
23.8 |
10 |
0.11 |
antipyretic |
- |
6000a/ 14 |
|
caffeine (3) |
58-08-2 |
84 |
0.014 |
61.9 |
6.0 |
0.081 |
stimulant |
- |
40000e/ 77 |
|
caffeine (4) |
58-08-2 |
85 |
0.08 |
70.6 |
5.7 |
0.1 |
stimulant |
- |
40000e/ 77 |
|
cotinine (3) |
486-56-6 |
84 |
0.023 |
38.1 |
0.90 |
0.024 |
nicotine metabolite |
- |
-/0 |
|
cotinine (4) |
486-56-6 |
54 |
0.04 |
31.5 |
0.57 |
0.05 |
nicotine metabolite |
- |
-/0 |
|
1,7-dimethylxanthine (3) |
611-59-6 |
84 |
0.018 |
28.6 |
3.1d |
0.11d |
caffeine metabolite |
- |
-/0 |
|
ibuprofen (3) |
15687-27-1 |
84 |
0.018 |
9.5 |
1.0 |
0.20 |
antiinflammatory |
- |
-/0 |
|
Other Wastewater-Related Compounds |
|||||||||
|
1,4-dichlorobenzene (4) |
106-46-7 |
85 |
0.03 |
25.9 |
4.3 |
0.09 |
deodorizer |
75 |
1100c/190 |
|
2,6-di-tert-butylphenol (4) |
128-39-2 |
85 |
0.08 |
3.5 |
0.11d |
0.06d |
antioxidant |
- |
-/2 |
|
2,6-di-tert-butyl-1,4-benzoquinone (4) |
719-22-2 |
85 |
0.10 |
9.4 |
0.46 |
0.13 |
antioxidant |
- |
-/0 |
|
5-methyl-1H-benzotriazole (4) |
136-85-6 |
54 |
0.10 |
31.5 |
2.4 |
0.39 |
antiocorrosive |
- |
-/0 |
|
acetophenone (4) |
98-86-2 |
85 |
0.15 |
9.4 |
0.41 |
0.15 |
fragrance |
- |
155000e/21 |
|
anthracene (4) |
120-12-7 |
85 |
0.05 |
4.7 |
0.11 |
0.07 |
PAH |
- |
5.4e/188 |
|
benzo[a]pyrene (4) |
50-32-8 |
85 |
0.05 |
9.4 |
0.24 |
0.04 |
PAH |
0.2 |
1.5a/428 |
|
3-tert-butyl-4-hydroxy anisole (4) |
25013-16-5 |
85 |
0.12 |
2.4 |
0.2d |
0.1d |
antioxidant |
- |
870c/14 |
|
butylated hydroxy toluene (4) |
128-37-0 |
85 |
0.08 |
2.4 |
0.1d |
0.1d |
antioxidant |
- |
1440a/15 |
|
bis(2-ethylhexyl) adipate (4) |
103-23-1 |
85 |
2.0 |
3.5 |
10f |
3f |
plasticizer |
400 |
480a/9 |
|
bis(2-ethylhexyl) phthalate (4) |
117-81-7 |
85 |
2.5 |
10.6 |
20f |
7f |
plasticizer |
6 |
7500a/309 |
|
chemical (method) |
CASRN |
N |
RL ( |
freq (%) |
max ( |
med ( |
use |
MCL or HAL (23) ( |
lowest LC50 for the most sensitive indicator species ( |
|
Other Wastewater-Related Compounds |
|||||||||
|
bisphenol A (4) |
80-05-7 |
85 |
0.09 |
41.2 |
12 |
0.14 |
plasticizer |
- |
3600e/26 |
|
carbaryl (4) |
63-25-2 |
85 |
0.06 |
16.5 |
0.1d |
0.04d |
insecticide |
700 |
0.4a/1541 |
|
cis-chlordane (4) |
5103-71-9 |
85 |
0.04 |
4.7 |
0.1 |
0.02 |
insecticide |
2 |
7.4b/28 |
|
chlorpyrifos (4) |
2921-88-2 |
85 |
0.02 |
15.3 |
0.31 |
0.06 |
insecticide |
20 |
0.1a/1794 |
|
diazinon (4) |
333-41-5 |
85 |
0.03 |
25.9 |
0.35 |
0.07 |
insecticide |
0.6 |
0.56a/1040 |
|
dieldrin (4) |
60-57-1 |
85 |
0.08 |
4.7 |
0.21 |
0.18 |
insecticide |
0.2 |
2.6c/1540 |
|
diethylphthalate (4) |
84-66-2 |
54 |
0.25 |
11.1 |
0.42 |
0.2 |
plasticizer |
- |
12000c/129 |
|
ethanol,2-butoxy-phosphate (4) |
78-51-3 |
85 |
0.2 |
45.9 |
6.7 |
0.51 |
plasticizer |
- |
10400e/7 |
|
fluoranthene (4) |
206-44-0 |
85 |
0.03 |
29.4 |
1.2 |
0.04 |
PAH |
- |
74e/216 |
|
lindane (4) |
58-89-9 |
85 |
0.05 |
5.9 |
0.11 |
0.02 |
insecticide |
0.2 |
30c/1979 |
|
methyl parathion (4) |
298-00-0 |
85 |
0.06 |
1.2 |
0.01 |
0.01 |
insecticide |
2 |
12a/888 |
|
4-methyl phenol (4) |
106-44-5 |
85 |
0.04 |
24.7 |
0.54 |
0.05 |
disinfectant |
- |
1400a/74 |
|
naphthalene (4) |
91-20-3 |
85 |
0.02 |
16.5 |
0.08 |
0.02 |
PAH |
20 |
910c/519 |
|
N,N-diethyltoluamide (4) |
134-62-3 |
54 |
0.04 |
74.1 |
1.1 |
0.06 |
insect repellant |
- |
71250c/9 |
|
4-nonylphenol (4) |
251-545-23 |
85 |
0.50 |
50.6 |
40g |
0.8g |
nonionic detergent metabolite |
- |
130e/135 |
|
4-nonylphenol monoethoxylate (4) |
- |
85 |
1.0 |
45.9 |
20g |
1g |
nonionic detergent metabolite |
|
14450a/4 |
|
4-nonylphenol diethoxylate (4) |
- |
85 |
1.1 |
36.5 |
9g |
1g |
nonionic detergent metabolite |
- |
5500a/6 |
|
4-octylphenol monoethoxylate (4) |
- |
85 |
0.1 |
43.5 |
2g |
0.2g |
nonionic detergent metabolite |
- |
-/0 |
|
4-octylphenol diethoxylate (4) |
- |
85 |
0.2 |
23.5 |
1g |
0.1g |
nonionic detergent metabolite |
- |
-/0 |
|
phenanthrene (4) |
85-01-8 |
85 |
0.06 |
11.8 |
0.53 |
0.04 |
PAH |
- |
590a/192 |
|
phenol (4) |
108-95-2 |
85 |
0.25 |
8.2 |
1.3f |
0.7f |
disinfectant |
400 |
4000c/2085 |
|
phthalic anhydride (4) |
85-44-9 |
85 |
0.25 |
17.6 |
1f |
0.7f |
plastic manufacturing |
- |
40400c/5 |
|
pyrene (4) |
129-00-0 |
85 |
0.03 |
28.2 |
0.84 |
0.05 |
PAH |
- |
90.9a/112 |
|
tetrachloroethylene (4) |
127-18-4 |
85 |
0.03 |
23.5 |
0.70d |
0.07d |
solvent, degreaser |
5 |
4680c/147 |
|
triclosan (4) |
3380-34-5 |
85 |
0.05 |
57.6 |
2.3 |
0.14 |
antimicrobial disinfectant |
- |
180e/3 |
|
tri(2-chloroethyl) phosphate (4) |
115-96-8 |
85 |
0.04 |
57.6 |
0.54 |
0.1 |
fire retardant |
- |
66000b/8 |
|
tri(dichlorisopropyl) phosphate (4) |
13674-87-8 |
85 |
0.1 |
12.9 |
0.16 |
0.1 |
fire retardant |
- |
3600b/9 |
|
triphenyl phosphate (4) |
115-86-6 |
85 |
0.1 |
14.1 |
0.22 |
0.04 |
plasticizer |
- |
280c/66 |
|
Steroids and Hormones |
|||||||||
|
cis-androsterone (5) |
53-41-8 |
70 |
0.005 |
14.3 |
0.214 |
0.017 |
urinary steroid |
- |
-/0 |
|
cholesterol (4) |
57-88-5 |
85 |
1.5 |
55.3 |
10d |
1d |
plant/animal steroid |
- |
-/0 |
|
cholesterol (5) |
57-88-5 |
70 |
0.005 |
84.3 |
60h |
0.83 |
plant/animal steroid |
- |
-/0 |
|
coprostanol (4) |
360-68-9 |
85 |
0.6 |
35.3 |
9.8d |
0.70d |
fecal steroid |
- |
-/0 |
|
coprostanol (5) |
360-68-9 |
70 |
0.005 |
85.7 |
150h |
0.088 |
fecal steroid |
- |
-/0 |
|
equilenin (5) |
517-09-9 |
70 |
0.005 |
2.8 |
0.278 |
0.14 |
estrogen replacement |
- |
-/0 |
|
equilin (5) |
474-86-2 |
70 |
0.005 |
1.4 |
0.147 |
0.147 |
estrogen replacement |
- |
-/0 |
|
17 |
57-63-6 |
70 |
0.005 |
15.7 |
0.831 |
0.073 |
ovulation inhibitor |
- |
-/22 |
|
17 |
57-91-0 |
70 |
0.005 |
5.7 |
0.074 |
0.03 |
reproductive hormone |
- |
-/0 |
|
17 |
50-28-2 |
85 |
0.5 |
10.6 |
0.2d |
0.16d |
reproductive hormone |
- |
-/0 |
|
17 |
50-28-2 |
70 |
0.005 |
10.0 |
0.093 |
0.009 |
reproductive hormone |
- |
-/0 |
|
estriol (5) |
50-27-1 |
70 |
0.005 |
21.4 |
0.051 |
0.019 |
reproductive hormone |
- |
-/0 |
|
estrone (5) |
53-16-7 |
70 |
0.005 |
7.1 |
0.112 |
0.027 |
reproductive hormone |
- |
-/11 |
|
mestranol (5) |
72-33-3 |
70 |
0.005 |
10.0 |
0.407 |
0.074 |
ovulation inhibitor |
- |
-/0 |
|
19-norethisterone (5) |
68-22-4 |
70 |
0.005 |
12.8 |
0.872 |
0.048 |
ovulation inhibitor |
- |
-/0 |
|
progesterone (5) |
57-83-0 |
70 |
0.005 |
4.3 |
0.199 |
0.11 |
reproductive hormone |
- |
-/0 |
|
stigmastanol (4) |
19466-47-8 |
54 |
2.0 |
5.6 |
4d |
2d |
plant steroid |
- |
-/0 |
|
testosterone (5) |
58-22-0 |
70 |
0.005 |
2.8 |
0.214 |
0.116 |
reproductive hormone |
- |
-/4 |
a Daphnia magna (water flea) - 48 h exposure LC50.b
Other species and variable conditions.c Oncorhynchus mykiss
(rainbow trout) - 96 h exposure LC50.d
Concentration estimated - average recovery <60%.e Pimephales
promelas (fathead minnow) - 96 h exposure LC50.f
Concentration estimated - compound routinely detected in laboratory blanks.g
Concentration estimated - reference standard prepared from a technical mixture.h
Concentration estimated - value greater than highest point on calibration curve.i
Compounds suspected of being hormonally active are in bold (4,
22)
To determine the environmental extent of 95 OWCs (Table 1![]()
)
in susceptible streams, five separate analytical methods were used. Each method
was developed independently in different laboratories, with somewhat different
data objec tives, such as identifying hormones versus identifying antibiotics.
As a result of these differing objectives, varying approaches were used in the
development of the five analytical methods. For example, select methods (Methods
1-3 below) used filtered water for solid-phase extraction (SPE) with liquid
chromatography/mass spectrometry posi tive-ion electrospray (LC/MS-ESI(+))
analysis, while others (Methods 4 and 5 below) used whole-water continuous
liquid-liquid extraction (CLLE) with capillary gas chroma tography/mass
spectrometry (GC/MS) analysis.
All methods use selected ion monitoring (SIM) for improved sensitivity, thus,
only the target compounds were reported with no attempt to report data for
nontarget compounds. Target compounds within each method were selected from the
large number of chemical possibilities based upon usage, toxicity, potential
hormonal activity, and persistence in the environment. Some compounds that fit
the above criteria, however, could not be included (such as amoxicillin,
roxarsone, polybrominated diphenyl ethers) because they were either incompatible
with the correspond ing method or reference standards were not available.
Positive identification of a compound required elution within the expected
retention time window. In addition, the sample spectra and ion abundance ratios
were required to match that of the reference standard compounds. The base-peak
ion was used for quantitation, and, if possible, two qualifier ions were used
for confirmation. After qualitative criteria were met, compound concentrations
were calculated from 5 to 8 point calibration curves (generally from 0.01 to
10.0
g/L) using internal standard quantitation. Methods 1 and
2 process calibration standards through the extraction procedure, which
generally corrects concentrations for method losses but not matrix effects.
Methods 3-5 do not extract calibration standards, thus the reported concentra
tions are not corrected for method losses. Reporting levels (RLs) were
determined for each method by either an evaluation of instrument response,
calculation of limit of detection, or from a previously published procedure (25).
RLs were adjusted based on experience with the compounds in each method, known
interferences, or known recovery problems.
The following descriptions are intended to provide a brief overview of the
five analytical methods used for this study. More comprehensive method
descriptions are provided elsewhere (26-28)
Method 1. This method targets 21 antibiotic compounds (Table 1) in
500-mL filtered water samples using modifica tions from previously described
methods (26, 29)
L using N2
and a water bath of 55
C. Three hundred
L
of 20 mM of NH4C2H3OO (pH 5.7) was added to
sample eluate, vortexed, transferred to a glass chromatography vial, and frozen
until analysis. Samples were extracted as a set of 11 environmental samples, one
duplicate sample, two fortified ultrapure water spikes (check standards), and
two ultrapure water blanks.
Method 2. This method targets eight antibiotic compounds (Table
1) in filtered water samples. Complete details of this method have been
described previously (26). The antibiotics
were extracted and analyzed using SPE and SIM LC/MS-ESI(+). Samples were
prepared for extraction by adding 13C6-sulfamethazine and
meclocycline as surrogate standards, Na2EDTA, and H2SO4.
Target compounds were extracted using 60-mg HLB cartridges preconditioned with
CH3OH, NHCl, and distilled H2O. Target compounds were
eluted with CH3OH into a test tube containing the internal standard,
simatone. The extracts were then concentrated under N2 to
approximately 50
L, and mobile phase A (10 mM NH4H2O2
in 90/10 water/CH3OH with 0.3% CH2O2) was
added. The resulting solutions were transferred to amber autosampler vials to
prevent photodegradation of tetracyclines (30).
Mobile phase conditions are described in detail elsewhere (26).
For each compound, the proton adduct of the molecular ion (M + H)+ and at
least one confirming ion were acquired using LC/MS-ESI(+). All mass spectral
conditions are described in detail elsewhere (26).
Quantitation was based on the ratio of the base peak ion (M + H)+ of the analyte
to the base peak of the internal standard. Standard addition was used for
quantitation where each sample was analyzed with and without the addition of a
0.5
g/L spike to correct for suppression of the electrospray
signal.
Method 3. This method targets 21 human prescription and nonprescription drugs and their select metabolites (Table 1) in filtered water samples. Compounds were extracted from1 L water samples using SPE cartridges that contain 0.5 g of HLB (flow rate of 15 mL/min). After extraction, the adsorbed compounds were eluted with CH3OH followed by CH3OH acidified with C2HCl3O2. The two fractions were reduced under N2 to near dryness and then combined and brought to a final volume of 1 mL in 10% C2H3N:90% H2O buffered with NH4H2O2/CH2O2.
Compounds were separated and measured by high-performance liquid
chromatography (HPLC) using a polar (neutral silanol) reverse-phase octylsilane
(C8) HPLC column (Metasil Basic 3
m, 150 × 2.0 mm; Metachem
Technologies). The compounds were eluted with a binary gradient of mobile phase
A (aqueous NH4H2O2/CH2O2
buffer; 10 mM, pH 3.7) and mobile phase B (100% C2H3N).
Method 4. This method (27, 28)
Method 5. This method (28) targets 14 steroid compounds including several biogenic and synthetic reproductive hormones (Table 1). The CLLE extracts from the previously analyzed samples of Method 4 were derivatized and reanalyzed. Analysis of steroid and hormone compounds by GC/MS is enhanced by derivatization to deactivate the hydroxyl and keto functional groups. The technique used in this study is the formation of trimethylsilyl (TMS) ethers of the hydroxyl groups and oximes of the keto groups. Samples were stored in a silanizing reagent to prevent hydrolysis of the derivatives back to the free compound. Surrogate standards (d4estradiol and d7cholesterol) were added to the samples prior to derivatization to evaluate method performance. After derivatization, the samples were analyzed by GC/MS.
|
compound |
spike concn ( |
mean % recovery |
% RSD |
|
Method 1 |
|||
|
target compounds |
1.0 |
99.0 |
12.1 |
|
Method 2 |
|||
|
target compounds |
1.0 |
97.5 |
12.2 |
|
13C6-sulfamethazine |
1.0 |
80.0 |
20.0 |
|
meclocycline |
1.0 |
80.0 |
20.0 |
|
Method 3 |
|||
|
target compounds |
0.5 |
85.1 |
11.6 |
|
C13-phenacetin |
1.0 |
96.8 |
14.0 |
|
Method 4 |
|||
|
target compounds |
1.0 |
81.0 |
11.0 |
|
d21-BHT |
2.0 |
63.0 |
25.0 |
|
n-nonylphenol |
2.0 |
83.0 |
20.0 |
|
Method 5 |
|||
|
target compounds |
NA |
NA |
NA |
|
d4-estradiola |
0.047 |
128.8 |
42.0 |
|
d3-testosteronea |
0.051 |
148.5 |
47.3 |
|
d7-cholesterola |
0.053 |
116.9 |
55.9 |
a Surrogate standard added after CCLE extraction but prior to derivitization.b RSD, relative standard deviation; NA, not currently available.
Quality Assurance Protocol. At least one fortified laboratory spike and one laboratory blank was analyzed with each set of 10-16 environmental samples. Most methods had surrogate compounds added to samples prior to extraction to monitor method performance. A summary of recoveries for target compounds and surrogate compounds in environmental samples (Table 2) indicates the general proficiency of the methods. The RL (Table 1) is equivalent to the lowest concentration standard that could be reliably quantitated. The compound concentrations reported below the RL or the lowest calibration standard were estimated as indicated in Figure 2. The concentration of compounds with <60% recovery, routinely detected in laboratory blanks, or prepared with technical grade mixtures, was also considered estimated (Table 1).
![]() |
Figure 2 Measured concentrations for the 30 most frequently detected organic wastewater contaminants. Boxplots show concentration distribution truncated at the reporting level. Estimated values below the reporting level are shown. Estimated maximum values for coprostanol and cholesterol obtained from Method 5 (Table 1) are not shown. The analytical method number is provided (in parentheses) at the end of each compound name. An explanation of a boxplot is provided in Figure 3. |
The laboratory blanks were used to assess potential sample contamination. Blank contamination was not subtracted from environmental results. However, environmental concentra tions within twice the values observed in the set blank were reported as less than the RL.
A field quality assurance protocol was used to determine the effect, if any,
of field equipment and procedures on the concentrations of OWCs in water
samples. Field blanks, made from laboratory-grade organic free water, were
submitted for about 5% of the sites and analyzed for all of the 95 OWCs. Field
blanks were subject to the same sample processing, handling, and equipment as
the stream samples. To date, one field blank had a detection of coprostanol and
testosterone, one field blank had a detection of naphthalene and
tri(dichlorisopropyl)phosphate, and one field blank hada detection of
naphthalene, 4-nonylphenol, phenol, 4-tert-octylphenol monoethoxylate,
and ethanol,2-butoxy-phosphate. Most of these detections were near their
respective RLs verifying the general effectiveness of the sampling protocols
used for this study. In addition all field blanks had low level concentrations
of cholesterol being measured using Method 5 (median concentration = 0.09
g/L)
documenting its ubiquitous nature in the environment. Cholesterol concentrations
from 0.005 to 0.18
g/L obtained through Method 5 were set to
less than the RL.
Compounds that were measured by more than one analytical method (Table 1;
Figure 3) also were used to evaluate the results for this study. The presence or
absence of these compounds were confirmed in 100% of the determinations for
sulfamerazine, and sulfathiazole; 98.8% for oxytetracycline, sulfadimethoxine,
sulfamethazine, and tetracycline; 98.6% for cholesterol and coprostanol; 97.6%
for chlortetracyline; 95.7% for 17
-estradiol;
94.4% for cotinine; 94.0% for trimethoprim; 89.1% for sulfamethoxazole; 86.4%
for codeine; and 83.3% for caffeine. The comparisons for codeine, caffeine, and
cotinine may have been affected by the differing extractions (SPE versus CLLE)
as well as differing types of sample (filtered versus whole water).
![]() |
Figure 3 Comparison of concentrations of select compounds that were measured using two different methods with significantly different reporting levels. Boxplots show concentration distribution truncated at the reporting level. Estimated values below the reporting level are shown. Estimated maximum values for chloesterol and coprostanol obtained from Method 5 (Table 1) are not shown. The analytical method number is provided (in parentheses) at the end of each compound name. |
An interlaboratory comparison of Methods 1 and 3 was conducted using two
reagent water blanks and 24 reagent water spikes prepared at concentrations
ranging from 0.5 to 1.1
g/L for two frequently detected
antibiotics (sulfamethoxazole and trimethoprim). The results demonstrated that
both methods are accurately confirming the presence of sulfamethoxazole and
trimethoprim in water, with the measured concentrations being within a factor of
3 or better of the actual concentrations for these compounds. No false positives
or false negatives occurred for this experiment.
One or more OWCs were found in 80% of the 139 streams sampled for this study. The high overall frequency of detection for the OWCs is likely influenced by the design of this study, which placed a focus on stream sites that were generally considered susceptible to contamination (i.e. downstream of intense urbanization and livestock production). In addi tion, select OWCs (such as cholesterol) can also be derived from nonanthropogenic sources. Furthermore, some of the OWCs were selected because previous research (28) identified them as prevalent in the environment. Thus, the results of this study should not be considered representative of all streams in the United States. A previous investigation of streams downstream of German municipal sewage treatment plants also found a high occurrence of OWCs (31).
A large number of OWCs (82 out of 95) were detected at least once during this
study (Table 1). Only eight antibiotics and five other prescription drugs were
not detected in the samples analyzed (Table 1). Measured concentrations were
generally low (median detectable concentrations generally <1
g/L,
Table 1), with few compounds exceeding drinking-water guidelines, health
advisories, or aquatic-life criteria (Table 1). The concentration of benzo[a]pyrene
exceeded its maximum contaminant level (MCL) of 0.2
g/L at
one site and bis(2-ethylhexyl)phthalate concentrations exceeded its MCL of 6.0
g/L
at five sites. In addition, aquatic-life criteria were exceeded for chlorpyrifos
(Table 1) at a single site. However, many of the 95 OWCs do not have such
guidelines or criteria determined (Table 1). In fact, much is yet to be known
about the potential toxicological effects of many of the OWCs under
investigation (1). For many OWCs, acute
effects to aquatic biota appear limited because of the low concentrations
generally occurring in the environment (24, 32-34)
The 30 most frequently detected compounds represent a wide variety of uses
and origins including residential, industrial, and agricultural sources (Figure
2, Table 1). Only about 5% of the concentrations for these compounds exceeded 1
g/L.
Over 60% of these higher concentrations were derived from cholesterol and three
detergent metabolites (4-nonyphenol, 4-nonylphenol monoethoxylate, and
4-nonylphenol diethoxylate). The frequent detection of cotinine,
1,7-dimethylxanthine, erythromycin-H2O, and other OWC metabolites
demonstrate the importance of obtaining data on degradates to fully understand
the fate and transport of OWCs in the hydrologic system. In addition, their
presence suggests that to accurately determine the overall effect on human and
environmental health (such as pathogen resistance and genotoxicity) from OWCs,
their degradates should also be considered. The presence of the parent compound
and/or their select metabolites in water resources has previously been
documented for OWCs (40, 41)
Many of the most frequently detected compounds (Figure 2) were measured in unfiltered samples using Method 4. Thus, their frequencies of detection may be somewhat higher because concentrations being measured include both the dissolved and particulate phases, whereas concentrations measured by Methods 1-3 include just the dissolved phase. For example, about 90% of the coprostanol discharged from sewage effluents has been shown to be associated with particulate matter (44). Thus, the concentration and frequency of detection for select compounds would likely have been reduced if sample filtration had taken place.
Variations in RL also influence the frequency of OWC detection (Figure 2). For example, the detection of 4-nonylphenol would likely have been much greater if an order of magnitude lower RL (similar to other OWCs) could have been achieved. The effect of RL on frequencies of detection is more clearly demonstrated by comparison of concentrations of select compounds that were measured using multiple analytical methods (Figure 3). As expected, the frequency of detection for a given compound was higher with the lower RL. The only exception being caffeine, where filtration of Method 3 may have reduced caffeine concentrations compared to that of the unfiltered Method 4. Figures 2 and 3 also demonstrate the importance of estimated values (45) below the RL. Clearly the numerous estimated concentrations illustrate that the current RLs are not low enough to accurately characterize the total range of OWC concentrations in the stream samples and that the frequencies of detection for this study are conservative.
To obtain a broader view of the results for this study, the 95 OWCs were divided into 15 groups based on their general uses and/or origins. The data show two environmental determinations: frequency of detection (Figure 4A) and percent of total measured concentration (Figure 4B) for each group of compounds. These two views show a vastly different representation of the data. In relation to frequency of detection, there were a number of groups that were frequently detected, with seven of the 15 groups being found in over 60% of the stream samples (Figure 4A). However, three groups (detergent metabolites, plasticizers, and steroids) contributed almost 80% of the total measured concentration (Figure 4B).
![]() |
Figure 4 Frequency of detection of organic wastewater contaminants by general use category (4A), and percent of total measured concentration of organic wastewater contaminants by general use category (4B). Number of compounds in each category shown above bar. |
For those groups of compounds that have received recent public
attention-namely antibiotics, nonprescription drugs, other prescription drugs,
and reproductive hormones (1, 2, 10)
g/L) to select hormones can illicit deleterious
effects in aquatic species (7, 46, 47)
Mixtures of various OWCs were prevalent during this study, with most (75%) of
the streams sampled having more than one OWC identified. In fact, a median of
seven OWCs were detected in these streams, with as many as 38 compounds found in
a given streamwater sample (Figure 5). Because only a subset of the 95 OWCs were
measured at most sites collected during the first year of study, it is suspected
that the median number of OWCs for this study is likely underestimated. Although
individual compounds were generally detected at low-levels, total concentrations
of the OWCs commonly exceeded 1
g/L (Figure 5). In addition,
33 of the 95 target OWCs are known or suspected to exhibit at least weak
hormonal activity with the potential to disrupt normal endocrine function (4,
7, 8, 10, 12, 22, 36, 37, 48-50)
g/L. Aquatic species exposed to estrogenic compounds
have been shown to alter normal hormonal levels (7,
48, 51)
![]() |
Figure 5 Relation between total concentration (summation from all detections) and number of organic wastewater contaminants found per water sample (Spearman's rank correlation coefficient = 0.94, P < 0.001). |
The results of this study document that detectable quantities of OWCs occur
in U.S. streams at the national scale. This implies that many such compounds
survive wastewater treatment (1, 6, 58)
Although previous research has also shown that antibiotics (60),
other prescription drugs (1, 2, 19, 61-63)
The authors wish to acknowledge the USGS scientists and field technicians who provided essential assistance to this project by identifying candidate stream sites across the United States and in collecting and processing stream samples. In addition, the authors thank Michele Lindsey, Jeff Cahill, and Greg Brown for their important contributions to developing the analytical methods being used. The authors also acknowledge Steffanie Keefe for her efforts in compiling the existing ecotoxicological data, Jessica Hopple for her as sistance in generating select figures for this paper, and Kymm Barnes for her assistance in compiling the water-quality data for this study. This project was supported by the U.S. Geological Survey, Toxic Substances Hydrology Program. The use of trade, firm, or brand names in this paper is for identification purposes only and does not constitute endorsement by the U.S. Geological Survey.
* Corresponding author phone: (319)358-3614; fax: (319)358-3606; e-mail: dwkolpin@usgs.gov.
1. Daughton, C. G.; Ternes, T. A. Environ. Health Perspect. 1999,
107 (Supplement 6), 907-938.
2. Halling-Sorensen, B.; Nielson, S. N.; Lanzky, P. F.; Ingerslev, F.; Holten
Lutzhoft, J.; Jorgensen, S. E. Chemosphere 1998, 35,
357-393.
3. Meyer, M. T.; Bumgarner, J. E.; Varns, J. L.; Daughtridge, J. V.; Thurman,
E. M.; Hostetler, K. A. Sci. Total Environ. 2000, 248,
181-187.
4. National Research Council. Hormonally active agents in the environment; National Academy Press: Washington, DC, 1999; 430 pp.
5. Jorgensen, S. E.; Halling-Sorensen, B. Chemosphere 2000, 40,
691-699.
6. Sedlak, D. L.; Gray, J. L.; Pinkston, K. E. Envrion. Sci. Technol. 2000,
34, 509A-515A.
7. Purdom, C. E.; Hardiman, P. A.; Bye, V. J.; Eno, N. C.; Tyler, C. R.;
Sumpter, J. P. Chem. Ecol. 1994, 8, 275-285.
8. White, R.; Jobling, S.; Hoare, S. A.; Sumpter, J. P.; Parker, M. G. Endocrinology
1994, 135, 175-182.
9. Sharpe, R. M.; Skakkebaek, N. E. Lancet 1993, 341,
1392-1395.
10. Panter, G. H.; Thompson, R. S.; Sumpter, J. P. Environ. Sci. Technol.
2000, 34, 2756-2760.
11. Harrison, P. T. C.; Holmes, P.; Humfrey, C. D. N. Sci. Total Environ.
1997, 205, 97-106.
12. Jobling, S.; Nolan, M.; Tyler, C. R.; Brighty, G.; Sumpter, J. P. Environ.
Sci. Technol. 1998, 32, 2498-2506.
13. Davis, D. L.; Bradlow, H. L. Sci. Am. 1995, 273,
166-172.
14. DuPont, H. L.; Steele, J. H. Rev. Infect. Dis. 1987, 9,
447-460.
15. Gilliver, M. A.; Bennett, M.; Begon, M.; Hazel, S. M.; Hart, C. A. Nature
1999, 401, 233-234.
16. Khachatourians, G. G. Can. Med. Assoc. J. 1998, 159,
1129-1136.
17. Smith, K. E.; Besser, J. M.; Hedberg, C. W.; Leano, F. T.; Bender, J. B.;
Wicklund, J. H.; Johnson, B. P.; Moore, K. A.; Osterholm, M. T. N. Engl. J.
Med. 1999, 340, 1525-1532.
18. Sumpter, J. P.; Jobling, S. Environ. Health Perspect. 1995,
103, 174-178.
19. Ayscough, N. J.; Fawell, J.; Franklin, G.; Young, W. Review of human pharmaceuticals in the environment; Environment Agency, R&D Technical Report P390; 2000.
20. http://toxics.usgs.gov/regional/emc.html.
21. Shelton, L. R. Open-File Rep., U.S. Geol. Surv. 1994, No. 94-455.
22. Foran, C. M.; Bennett, E. R.; Benson, W. H. Mar. Environ. Res. 2000,
50, 153-156.
23. U.S. Environmental Protection Agency. U.S. EPA No. 822-B-00-001; U.S. Government Printing Office; Washington, DC, 2000.
24. U.S. Environmental Protection Agency Ecotoxicology database. http://www.epa.gov/medecotx/quicksearch.htm. (accessed May 2001).
25. U.S. Environmental Protection Agency. Guidelines establishing test procedures for the analysis of pollutants (App. B to Part 136, Definition and procedure for the determination of the method detection limit) U.S. Code of Federal Regulations, Title 40, revised as of July 1, 1992.
26. Lindsey, M. E.; Meyer, M.; Thurman, E. M. Anal. Chem. 2001,
73, 4640-4646.
27. Brown, G. K.; Zaugg, S. D.; Barber, L. B. Water-Resour. Invest. Rep.-U.S.
Geol Surv. 1999, No. 99-4018B, pp 431-435.
28. Barber, L. B.; Brown, G. K.; Zaugg, S. D. In Analysis of Environmental Endocrine Disruptors; Keith, L. H., Jones-Lepp, T. L., Needham, L. L., Eds.; ACS Symposium Series 747; American Chemical Society: Washington, DC, 2000; pp 97-123.
29. Hirsch, R.; Ternes, T. A.; Haberer, K.; Mehlich, A.; Ballwanz, F.; Kratz,
K. L. J. Chromatogr. A 1998, 815, 213-223.
30. Mitscher, L. A. The Chemistry of the Tetracycline Antibiotics; Marcel Dekker: New York, Basel, 1978.
31. Heberer, T.; Schmidt-Baumler, K.; Stan, H. J. Acta Hydrochim.
Hydrobiol. 1998, 26, 272-278.
32. Baguer, A. J.; Jensen, J.; Krogh, P. H. Chemosphere 2000, 40,
751-757.
33. Lutzhoft, H. C.; Halling-Sorensen, B.; Jorgensen, S. E. Arch. Environ.
Contam. Toxicol. 1999, 36, 1-6.
34. Wollenberger, L.; Halling-Sorensen, B.; Kusk, K. O. Chemosphere 2000,
40, 723-730.
35. Hartmann, A.; Golet, E. M.; Gartiser, S.; Alder, A. C.; Koller, T.;
Widmer, R. M. Arch. Environ. Contam. Toxicol. 1999, 36,
115-119.
36. Fong, P. P. Biol. Bull. 1998, 194, 143-149.
37. Sohoni, P.; Tyler, C. R.; Hurd, K.; Caunter, J.; Hetheridge, M.;
Williams, T.; Woods, C.; Evans, M.; Toy, R.; Gargas, M.; Sumpter, J. P. Environ.
Sci. Technol. 2001, 35, 2917-2925.
38. Harris, C. A.; Santos, E. M.; Janbakhsh, A.; Pottinger, T. G.; Tyler, C.
R.; Sumpter, J. P. Environ. Sci. Technol. 2001, 35,
2909-2916.
39. Chee-Sanford, J. C.; Aminov, R. I.; Krapac, I. J.; Garrigues-Jeanjean,
N.; Mackie, R. I. Appl. Environ. Microbiol. 2001, 67,
1949-1502.
40. Buser, H.-R.; Poiger, T.; Muller, M. D. Environ. Sci. Technol. 1998,
32, 3449-3456.
41. Buser, H.-R.; Poiger, T.; Muller, M. D. Environ. Sci. Technol. 1999,
33, 2529-2535.
42. Kolpin, D. W.; Thurman, E. M.; Linhart, S. M. Sci. Total Environ. 2000,
248, 115-122.
43. Clark, G. M.; Goolsby, D. A. Sci. Total Environ. 2000, 248,
101-113.
44. Venkatesan, M. I.; Kaplan, I. R. Environ. Sci. Technol. 1990,
24, 208-213.
45. Childress, C. J. O.; Foreman, W. T.; Connor B. F.; Maloney, T. J. Open-File
Rep.-U.S. Geol. Surv. 1999, No. 99-193.
46. Baronti, C.; Curini, R.; D'Ascenzo, G.; Di Corcia, A.; Gentili, A.;
Samperi, R. Environ. Sci. Technol. 2000, 34, 5059-5066.
47. Routledge, E. J.; Sheahan, D.; Desbrow, C.; Sumpter, J. P.; Waldock, M. Environ.
Sci. Technol. 1998, 32, 1559-1565.
48. Lye, C. M.; Frid, C. L. J.; Gill, M. E.; Cooper, D. W.; Jones, D. M. Environ.
Sci. Technol. 1999, 33, 1009-1014.
49. Swann, J. M.; Schultz, T. W.; Kennedy, J. R. Arch. Environ. Contam.
Toxicol. 1996, 30, 188-194.
50. Keith, T. L.; Snyder, S. A.; Naylor, C. G.; Staples, C. A.; Sumer, C.;
Kannan, K.; Giesy, J. P. Environ. Sci. Technol. 2001, 35,
10-13.
51. Folmar, L. C.; Denslow, N. D.; Kroll, K.; Orlando, E. F.; Enblom, J.;
Marcino, J.; Metcalfe, C.; Guillette, L. J., Jr. Arch. Environ. Contam.
Toxicol. 2001, 40, 392-398.
52. Kolpin, D. W.; Barbash, J. E.; Gilliom, R. J. Ground Water 2000,
38, 858-863.
53. Stackelberg, P. E.; Kauffman, L. J.; Ayers, M. A.; Baehr, A. L. Environ.
Toxicol. Chem. 2001, 20, 853-865.
54. Marinovich, M.; Ghilardi, F.; Galli, C. L. Toxicology 1996,
108, 201-206.
55. Thompson, H. M. Ecotoxicology 1996, 5, 59-81.
56. Thorpe, K. L.; Hutchinson, T. H.; Hetheridge, M. J.; Scholze, M.; Sumpter,
J. P.; Tyler, C. R. Environ. Sci. Technol. 2001, 35,
2476-2481.
57. Porter, W. P.; Jaeger, J. W.; Carlson, I. H. Toxicol. Ind. Health 1999,
15, 133-150.
58. Kuch, H. M.; Ballschmiter, K. Environ. Sci. Technol. 2001, 35,
3201-3206.
59. Al-Ahmad, A.; Daschner, F. D.; Kummerer, K. Arch. Environ. Contam.
Toxicol. 1999, 37, 158-153.
60. Hirsch, R.; Ternes, T.; Haberer, K.; Kratz, K. Sci. Total Environ.
1999, 225, 109-118.
61. Koenig, B. G.; Metcalfe, C. D.; Ternes, T.; Hirsch, R. SETAC
Proceedings 2000, 76.
62. Stumpf, M.; Ternes, T. A.; Wilken, R.; Rodriques, S. V.; Baumann, W. Sci.
Total Environ. 1999, 225, 135-141.
63. Ternes, T. A. Water Res. 1998, 32, 3245-3260.
64. Seiler, R. L.; Zaugg, S. D.; Thomas, J. M.; Howcroft, D. L. Ground
Water 1999, 37, 405-410.
65. Heberer, T. J. Hydrol. 2002 (in press).
66. Tolls, J. Environ. Sci. Technol. 2001, 35,
3397-3406.
|
chemical (method) |
CASRN |
N |
RL ( |
freq (%) |
max ( |
med ( |
use |
MCL or HAL (23) ( |
lowest LC50 for the most sensitive indicator species ( |
|
Veterinary and Human Antibiotics |
|||||||||
|
carbodox (1) |
6804-07-5 |
104 |
0.10 |
0 |
ND |
ND |
antibiotic |
- |
-/1 |
|
chlortetracycline (1) |
57-62-5 |
115 |
0.05 |
0 |
ND |
ND |
antibiotic |
- |
88000a/3 |
|
chlortetracycline (2) |
57-62-5 |
84 |
0.10 |
2.4 |
0.69 |
0.42 |
antibiotic |
- |
88000a/3 |
|
ciprofloxacin (1) |
85721-33-1 |
115 |
0.02 |
2.6 |
0.03 |
0.02 |
antibiotic |
- |
-/0 |
|
doxycycline (1) |
564-25-0 |
115 |
0.1 |
0 |
ND |
ND |
antibiotic |
- |
-/0 |
|
enrofloxacin (1) |
93106-60-6 |
115 |
0.02 |
0 |
ND |
ND |
antibiotic |
- |
40b/29 |
|
erythromycin-H2O (1) |
114-07-8 |
104 |
0.05 |
21.5 |
1.7 |
0.1 |
erythromycin metabolite |
- |
665000b/35 |
|
lincomycin (1) |
154-21-2 |
104 |
0.05 |
19.2 |
0.73 |
0.06 |
antibiotic |
- |
-/0 |
|
norfloxacin (1) |
70458-96-7 |
115 |
0.02 |
0.9 |
0.12 |
0.12 |
antibiotic |
- |
-/6 |
|
oxytetracycline (1) |
79-57-2 |
115 |
0.1 |
0 |
ND |
ND |
antibiotic |
- |
102000a/46 |
|
oxytetracycline (2) |
79-57-2 |
84 |
0.10 |
1.2 |
0.34 |
0.34 |
antibiotic |
- |
102000a/46 |
|
roxithromycin (1) |
80214-83-1 |
104 |
0.03 |
4.8 |
0.18 |
0.05 |
antibiotic |
- |
-/0 |
|
sarafloxacin (1) |
98105-99-8 |
115 |
0.02 |
0 |
ND |
ND |
antibiotic |
- |
-/0 |
|
sulfachloropyridazine (2) |
80-32-0 |
84 |
0.05 |
0 |
ND |
ND |
antibiotic |
- |
-/0 |
|
sulfadimethoxine (1) |
122-11-2 |
104 |
0.05 |
0 |
ND |
ND |
antibiotic |
- |
-/5 |
|
sulfadimethoxine (2) |
122-11-2 |
84 |
0.05 |
1.2 |
0.06 |
0.06 |
antibiotic |
- |
-/5 |
|
sulfamerazine (1) |
127-79-7 |
104 |
0.05 |
0 |
ND |
ND |
antibiotic |
- |
100000c/17 |
|
sulfamerazine (2) |
127-79-7 |
84 |
0.05 |
0 |
ND |
ND |
antibiotic |
- |
100000c/17 |
|
sulfamethazine (1) |
57-68-1 |
104 |
0.05 |
4.8 |
0.12 |
0.02 |
antibiotic |
- |
100000c 17 |
|
sulfamethazine (2) |
57-68-1 |
84 |
0.05 |
1.2 |
0.22 |
0.22 |
antibiotic |
- |
100000c/17 |
|
sulfamethizole (1) |
144-82-1 |
104 |
0.05 |
1.0 |
0.13 |
0.13 |
antibiotic |
- |
-/0 |
|
sulfamethoxazole (1) |
723-46-6 |
104 |
0.05 |
12.5 |
1.9 |
0.15 |
antibiotic |
- |
-/0 |
|
sulfamethoxazole (3) |
723-46-6 |
84 |
0.023 |
19.0 |
0.52 |
0.066 |
antibiotic |
- |
-/0 |
|
sulfathiazole (1 |